Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-19 Sale | 2024-08-20 6:46 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 9,733 | $15.28 | $148,720 | 43,735 (Direct) | View |
| 2024-08-19 Sale | 2024-08-20 6:43 pm | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 9,534 | $15.28 | $145,680 | 52,177 (Direct) | View |
| 2024-08-19 Sale | 2024-08-20 6:40 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 31,747 | $15.28 | $485,094 | 186,555 (Direct) | View |
| 2024-06-10 Sale | 2024-06-11 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 975 | $14.79 | $14,420 | 34,564 (Direct) | View |
| 2024-05-02 Sale | 2024-05-03 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 3,503 | $16.94 | $59,341 | 52,498 (Direct) | View |
| 2024-05-02 Sale | 2024-05-03 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 3,477 | $16.94 | $58,900 | 62,578 (Direct) | View |
| 2024-05-02 Sale | 2024-05-03 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 1,326 | $16.94 | $22,462 | 22,158 (Direct) | View |
| 2024-05-02 Sale | 2024-05-03 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 11,427 | $16.94 | $193,573 | 222,404 (Direct) | View |
| 2024-04-08 Sale | 2024-04-09 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 26,574 | $17.87 | $474,877 | 317,600 (Direct) | View |
| 2024-04-08 Sale | 2024-04-09 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 2,568 | $17.87 | $45,890 | 48,844 (Direct) | View |
| 2024-04-08 Sale | 2024-04-09 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 1,790 | $17.87 | $31,987 | 17,120 (Direct) | View |
| 2024-04-08 Sale | 2024-04-09 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2,716 | $17.87 | $48,535 | 39,293 (Direct) | View |
| 2024-03-27 Sale | 2024-03-27 8:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 5,140 | $17.9 | $92,006 | 153,316 (Direct) | View |
| 2024-03-27 Sale | 2024-03-27 7:58 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 17,714 | $17.9 | $317,081 | 405,293 (Direct) | View |
| 2024-03-27 Sale | 2024-03-27 7:57 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 5,434 | $17.9 | $97,269 | 131,461 (Direct) | View |
| 2024-02-26 Sale | 2024-02-27 6:13 pm | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 772 | $24.67 | $19,045 | 22,420 (Direct) | View |
| 2024-02-26 Sale | 2024-02-27 6:10 pm | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 624 | $24.67 | $15,394 | 32,539 (Direct) | View |
| 2024-02-26 Sale | 2024-02-27 6:07 pm | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 474 | $24.67 | $11,694 | 12,231 (Direct) | View |
| 2024-02-26 Sale | 2024-02-27 6:02 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 5,577 | $24.67 | $137,585 | 112,836 (Direct) | View |
| 2024-01-08 Sale | 2024-01-09 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 3,732 | $29.96 | $111,811 | 96,521 (Direct) | View |
| 2024-01-08 Sale | 2024-01-09 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 731 | $29.96 | $21,901 | 30,949 (Direct) | View |
| 2024-01-08 Sale | 2024-01-09 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary | 590 | $29.96 | $17,676 | 46,901 (Direct) | View |
| 2023-12-15 Sale | 2023-12-15 7:37 pm | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer | 2,000 | $28.3 | $56,600 | 11,025 (Direct) | View |
| 2023-11-20 Sale | 2023-11-21 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 4,960 | $22.64 | $112,294 | 70,045 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-12 Exercise | 2024-10-15 6:05 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Ndu Adora Director | 4,381 | $0 | 15,414 (Direct) | View |
| 2024-09-23 Option Award | 2024-09-25 6:53 pm | N/A 2034-09-22 | ACADIA PHARMACEUTICALS INC | ACAD | Adams Catherine Owen Chief Executive Officer | 353,261 | $0 | 353,261 (Direct) | View |
| 2024-08-16 Option Award | 2024-08-20 6:46 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 18,904 | $0 | 43,735 (Direct) | View |
| 2024-08-16 Option Award | 2024-08-20 6:43 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 18,653 | $0 | 52,177 (Direct) | View |
| 2024-08-16 Option Award | 2024-08-20 6:40 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 62,115 | $0 | 186,555 (Direct) | View |
| 2024-08-12 Option Award | 2024-08-13 6:05 pm | N/A 2034-08-11 | ACADIA PHARMACEUTICALS INC | ACAD | Thompson Elizabeth H.Z. EVP, Head of Research & Dev | 389,126 | $0 | 389,126 (Direct) | View |
| 2024-06-08 Exercise | 2024-06-11 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 1,893 | $0 | 34,564 (Direct) | View |
| 2024-05-29 Option Award | 2024-05-31 6:00 pm | N/A 2034-05-28 | ACADIA PHARMACEUTICALS INC | ACAD | Ndu Adora Director | 25,346 | $0 | 36,379 (Direct) | View |
| 2024-05-29 Exercise | 2024-05-31 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Ndu Adora Director | 6,652 | $0 | 36,379 (Direct) | View |
| 2024-05-29 Option Award | 2024-05-31 6:00 pm | N/A 2034-05-28 | ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director | 25,346 | $0 | 47,860 (Direct) | View |
| 2024-05-29 Exercise | 2024-05-31 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director | 6,652 | $0 | 47,860 (Direct) | View |
| 2024-05-29 Option Award | 2024-05-31 6:00 pm | N/A 2034-05-28 | ACADIA PHARMACEUTICALS INC | ACAD | Daly James M Director | 25,346 | $0 | 50,000 (Direct) | View |
| 2024-05-29 Exercise | 2024-05-31 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Daly James M Director | 6,652 | $0 | 50,000 (Direct) | View |
| 2024-05-29 Option Award | 2024-05-31 6:00 pm | N/A 2034-05-28 | ACADIA PHARMACEUTICALS INC | ACAD | HARRIGAN EDMUND Director | 25,346 | $0 | 51,000 (Direct) | View |
| 2024-05-29 Exercise | 2024-05-31 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | HARRIGAN EDMUND Director | 6,652 | $0 | 51,000 (Direct) | View |
| 2024-05-29 Option Award | 2024-05-31 6:00 pm | N/A 2034-05-28 | ACADIA PHARMACEUTICALS INC | ACAD | SOLAND DANIEL B Director | 25,346 | $0 | 60,000 (Direct) | View |
| 2024-05-29 Exercise | 2024-05-31 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | SOLAND DANIEL B Director | 6,652 | $0 | 60,000 (Direct) | View |
| 2024-05-29 Option Award | 2024-05-31 6:00 pm | N/A 2034-05-28 | ACADIA PHARMACEUTICALS INC | ACAD | Brege Laura Director | 25,346 | $0 | 45,500 (Direct) | View |
| 2024-05-29 Exercise | 2024-05-31 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Brege Laura Director | 6,652 | $0 | 45,500 (Direct) | View |
| 2024-05-29 Option Award | 2024-05-31 4:10 pm | N/A 2034-05-28 | ACADIA PHARMACEUTICALS INC | ACAD | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 82,610 | $0 | 39,619,339 (Indirect) | View |
| 2024-05-01 Exercise | 2024-05-03 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 6,814 | $0 | 52,498 (Direct) | View |
| 2024-05-01 Exercise | 2024-05-03 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 6,814 | $0 | 62,578 (Direct) | View |
| 2024-05-01 Exercise | 2024-05-03 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 2,596 | $0 | 22,158 (Direct) | View |
| 2024-05-01 Exercise | 2024-05-03 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 22,391 | $0 | 222,404 (Direct) | View |
| 2024-04-05 Exercise | 2024-04-09 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 51,999 | $0 | 317,600 (Direct) | View |
| 2024-04-05 Exercise | 2024-04-09 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 5,024 | $0 | 48,844 (Direct) | View |
| 2024-04-05 Exercise | 2024-04-09 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 3,499 | $0 | 17,120 (Direct) | View |
| 2024-04-05 Exercise | 2024-04-09 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 5,275 | $0 | 39,293 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 8:02 pm | N/A 2034-03-24 | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 22,532 | $0 | 22,532 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 8:00 pm | N/A 2034-03-24 | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 127,024 | $0 | 153,316 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 7:58 pm | N/A 2034-03-24 | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 321,117 | $0 | 405,293 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 7:57 pm | N/A 2034-03-24 | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 115,828 | $0 | 131,461 (Direct) | View |
| 2024-02-23 Exercise | 2024-02-27 6:13 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 1,353 | $0 | 22,420 (Direct) | View |
| 2024-02-23 Exercise | 2024-02-27 6:10 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 1,107 | $0 | 32,539 (Direct) | View |
| 2024-02-23 Exercise | 2024-02-27 6:07 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER | 840 | $0 | 12,231 (Direct) | View |
| 2024-02-23 Exercise | 2024-02-27 6:02 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 10,946 | $0 | 112,836 (Direct) | View |
| 2024-02-06 Option Award | 2024-02-08 5:09 pm | N/A 2034-02-05 | ACADIA PHARMACEUTICALS INC | ACAD | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | 152,478 | $0 | 152,478 (Direct) | View |
| 2024-01-06 Exercise | 2024-01-09 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO | 9,528 | $0 | 96,521 (Direct) | View |
| 2024-01-06 Exercise | 2024-01-09 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 1,287 | $0 | 30,949 (Direct) | View |
| 2024-01-06 Exercise | 2024-01-09 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary | 1,634 | $0 | 46,901 (Direct) | View |
| 2023-11-24 Gift | 2023-11-28 5:32 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director | 2,918 | $0 | 15,862 (Direct) | View |
| 2023-11-17 Exercise | 2023-11-21 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 9,912 | $0 | 70,045 (Direct) | View |